What is the appropriate pediatric intra‑abdominal infection dose of piperacillin‑tazobactam (Zosyn) for a 60‑kg child with uncomplicated appendicitis?

Piperacillin-Tazobactam Dosing for 60 kg Pediatric Patient with Appendicitis

For a 60 kg child with appendicitis, the appropriate dose is 3.375 g IV every 6 hours (not the adult dose), which translates to approximately 56 mg/kg/dose of the piperacillin component—well within the recommended pediatric range of 100 mg/kg every 8 hours for complicated intra-abdominal infections. 1

Weight-Based Dosing Considerations

• The FDA-approved pediatric dosing for appendicitis/peritonitis is 112.5 mg/kg (100 mg piperacillin/12.5 mg tazobactam component) every 8 hours for children older than 9 months with normal renal function. 1

• For a 60 kg patient, this weight-based calculation would yield 6.75 g every 8 hours (6 g piperacillin + 0.75 g tazobactam), which exceeds the maximum adult dose and should be capped at the adult dosing regimen. 2, 1

• The IDSA recommends an alternative pediatric dosing framework of 200-300 mg/kg/day of piperacillin component divided every 6-8 hours for complicated intra-abdominal infections, with maximum doses not exceeding adult dosing. 2

Recommended Dosing Algorithm for This Patient

Given this patient's weight of 60 kg (approaching adult body mass), the appropriate dose is 3.375 g IV every 6 hours, which provides:

• 12 g piperacillin and 1.5 g tazobactam daily (total 13.5 g/day) 1
• This translates to 200 mg/kg/day of piperacillin component, falling within the IDSA-recommended range 2
• This is the standard adult dose for complicated intra-abdominal infections and is appropriate for larger pediatric patients 1

Infusion Strategy

• Administer each dose over 30 minutes as per FDA labeling for standard appendicitis cases. 1

• Extended infusion (3-4 hours) is reserved for critically ill patients with septic shock, APACHE II ≥20, or severe nosocomial infections—not typically indicated for uncomplicated appendicitis 2

Common Pitfall to Avoid

• Do not blindly apply the weight-based pediatric formula (112.5 mg/kg every 8 hours) to larger children, as this would result in supratherapeutic dosing. The FDA label and IDSA guidelines both specify that pediatric doses should not exceed adult dosing limits 2, 1

• The 3.375 g dose every 6 hours provides adequate coverage for appendicitis-related polymicrobial infections (E. coli, Bacteroides, Pseudomonas) documented in pediatric studies 3

Duration of Therapy

• Continue therapy for 4-7 days for complicated intra-abdominal infections when adequate source control (appendectomy) is achieved. 2

• Therapy should not exceed what is necessary, as prolonged treatment increases risk of C. difficile colitis and antimicrobial resistance 4